Overview

sTErnAl heMostasiS Trial

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
Sternal bleeding remains an unsolved problem for cardiac surgery teams costing operative time, blood loss, and distraction from the critical operative field. As such, the following is an investigator-initiated trial to determine whether application of a topical hemostatic agent reduces sternal bleeding during cardiac surgery using sternotomy approach.
Phase:
PHASE4
Details
Lead Sponsor:
WakeMed Health and Hospitals
Collaborator:
Dilon Technologies